# Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis

> **NCT02370693** · PHASE2 · COMPLETED · sponsor: **Northwestern University** · enrollment: 9 (actual)

## Conditions studied

- Lung Diseases, Interstitial
- Systemic Sclerosis
- Scleroderma

## Interventions

- **DRUG:** Bortezomib
- **DRUG:** Placebo
- **DRUG:** Mycophenolate mofetil

## Key facts

- **NCT ID:** NCT02370693
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-12-16
- **Final completion:** 2020-01-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02370693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02370693, "Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02370693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*